Influenza

Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent the flu is by getting a flu vaccination each year. Every year in the United States, on average 5% to 20% of the population gets the flu; more than 200,000 people are hospitalized from flu complications, and; about 36,000 people die from flu-related causes. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.

Types of Influenza

Influenza is caused by three types of RNA viruses called influenza types A, B and C, which all belong to the family Orthomyxoviridae.

Influenza Immunization

Influenza Epidemiology

Influenza Prognosis

Influenza Symptoms

Influenza Treatments

Influenza Pandemics

Influenza Research

Influenza Infection in Animals

Should I get the Flu Shot?

Latest Influenza News and Research

Impact of an individually tailored educational application on vaccine attitudes of pregnant women and mothers

Researchers evaluated the impact of MomsTalkShots, a personalized application, on maternal attitudes toward vaccinations.

29 Nov 2022

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

Researchers investigate the genetic, immunological, and evolutionary factors that determine the vast variability observed in clinical manifestations of COVID-19.

28 Nov 2022

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Researchers determine the rates of thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia following COVID-19 vaccination and infection.

28 Nov 2022

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Researchers review potential areas for mRNA vaccine development against pathogenic viruses other than SARS-CoV-2.

28 Nov 2022

SARS-CoV-2 Omicron variant tends to spread more easily among children than prior strains

Researchers estimate the age-varying susceptibility to infection with the SARS-CoV-2 Omicron variant.

28 Nov 2022

Researchers uncovers a link between D-amino acids and severe viral infection

Just as bricks are key components in constructing a building, molecules known as amino acids are essential components in constructing proteins in the body.

28 Nov 2022

Are nasal-spray vaccines the solution to respiratory infectious diseases?

A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory illnesses.

28 Nov 2022

All trimesters of pregnancy carry the same COVID-19 risk

A study in the American Journal of Obstetrics & Gynecology MFM journal aimed to analyze the effect of the trimester of SARS-CoV-2 infection on the progression of the disease in pregnant women.

27 Nov 2022

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

25 Nov 2022

The potential of Sofosbuvir against COVID-19 neurological symptoms

Researchers discuss how SARS-CoV-2 infects cortical neurons and damages their synapses that form the connection between brain cells.

25 Nov 2022

New approach may serve as the basis for universal flu vaccines

Claudia Arevalo and colleagues have developed a mRNA lipid nanoparticle vaccine that contains antigens from all 20 known subtypes of influenza A and B viruses, a strategy that may serve as the basis for universal flu vaccines.

24 Nov 2022

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

All those eligible for the flu vaccine have been urged to come forward as cases rise to levels not seen since before the pandemic.

24 Nov 2022

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Researchers characterized the heterogeneity in the speed, magnitude, and timing of 13 SARS-CoV-2 variant transitions/waves.

23 Nov 2022

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

Researchers examined whether the mutational process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) itself has changed during the evolution of SARS-CoV-2.

23 Nov 2022

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Researchers conducted a retrospective analysis to investigate the impact of vaccine-sharing strategies on the heterogenous global distribution of COVID-19 vaccines.

22 Nov 2022

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Researchers explored active and passive vaccination among children against respiratory syncytial virus (RSV).

22 Nov 2022

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Researchers assessed the effectiveness of SARS-CoV and SARS-CoV-2 envelope proteins against HIV-1.

22 Nov 2022

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America's healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

21 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.

From The Native Antigen Company 21 Nov 2022

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Researchers demonstrated the efficacy of two World Health Organization (WHO)‒recommended alcohol-based hand rub solutions to inactivate the monkeypox virus (MPXV).

21 Nov 2022

Influenza

Overview

Influenza Immunization

Influenza Epidemiology

Influenza Prognosis

Feature Articles

Influenza Symptoms

Influenza Treatments

Influenza Pandemics

Influenza Research

Influenza Infection in Animals

Should I get the Flu Shot?

Latest Influenza News and Research

Impact of an individually tailored educational application on vaccine attitudes of pregnant women and mothers

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

SARS-CoV-2 Omicron variant tends to spread more easily among children than prior strains

Researchers uncovers a link between D-amino acids and severe viral infection

Are nasal-spray vaccines the solution to respiratory infectious diseases?

All trimesters of pregnancy carry the same COVID-19 risk

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

The potential of Sofosbuvir against COVID-19 neurological symptoms

New approach may serve as the basis for universal flu vaccines

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location

Study shows clear shifts in SARS-CoV-2 mutational spectrum during evolution

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

The Native Antigen Company introduces new range of influenza antigens

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Miracles Start in the Lab: the quest to find a vaccine to cure AIDS

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Drug Discovery eBook

Influenza

Overview

Feature Articles

Influenza Symptoms

Influenza Treatments

Influenza Pandemics

Influenza Research

Influenza Infection in Animals

Should I get the Flu Shot?

Latest Influenza News and Research

Miracles Start in the Lab: the quest to find a vaccine to cure AIDS

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Drug Discovery eBook

Newsletters you may be interested in